Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | EYA2 | O00167 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10326051 | 0.87 | TDP1 (0.64) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL175747 | 0.84 | TDP1 (0.50) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL429048 | 0.84 | TDP1 (0.50) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL431521 | 0.82 | TDP1 (0.55) | TDP1EYA2APPACEKDM4E | |
| Hydrochloric Acid SCHEMBL8981614 | 0.82 | TDP1 (0.48) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL1049790 | 0.82 | TDP1 (0.44) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL15955451 | 0.81 | KDM4E (0.31) | KDM4EKMT2AMEN1SMN1; SMN2 | |
| Acetic Acid SCHEMBL2866049 | 0.81 | KDM4E (0.38) | TDP1KDM4EALOX15LMNAKMT2A | |
| SCHEMBL28550794 | 0.80 | TDP1 (0.48) | TDP1EYA2APPACEKDM4E | |
| SCHEMBL28110603 | 0.80 | TDP1 (0.43) | TDP1EYA2APPACEKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104585228-A | MITIGATING NECROSIS IN TRANSGENIC GLYPHOSATE-TOLERANT COTTON PLANTS TREATED WITH HERBICIDAL GLYPHOSATE FORMULATIONS | MONSANTO TECHNOLOGY LLC | 2015-05-06 | — | — | CN | claimed |
| EP-1853115-A2 | MITIGATING NECROSIS IN TRANSGENIC GLYPHOSATE-TOLERANT COTTON PLANTS TREATED WITH HERBICIDAL GLYPHOSATE FORMULATIONS | Monsanto Technology, LLC (US) | 2007-11-14 | — | — | EP | claimed |
| WO-2006096617-A2 | MITIGATING NECROSIS IN TRANSGENIC GLYPHOSATE-TOLERANT COTTON PLANTS TREATED WITH HERBICIDAL GLYPHOSATE FORMULATIONS | MONSANTO TECHNOLOGY LLC (US) | 2006-09-14 | — | — | WO | claimed |
| US-20230102424-A1 | Mitigating Necrosis in Transgenic Glyphosate-Tolerant Cotton Plants Treated with Herbicidal Glyphosate Formulations | MONSANTO TECHNOLOGY LLC | 2023-03-30 | — | — | US | disclosed |
| US-20200236930-A1 | Mitigating Necrosis in Transgenic Glyphosate-Tolerant Cotton Plants Treated with Herbicidal Glyphosate Formulations | MONSANTO TECHNOLOGY LLC (US) | 2020-07-30 | — | — | US | disclosed |
| EP-1853115-B1 | MITIGATING NECROSIS IN TRANSGENIC GLYPHOSATE-TOLERANT COTTON PLANTS TREATED WITH HERBICIDAL GLYPHOSATE FORMULATIONS | MONSANTO TECHNOLOGY LLC (US) | 2019-01-09 | — | — | EP | disclosed |
| US-20170339950-A1 | Mitigating Necrosis in Transgenic Glyphosate-Tolerant Cotton Plants Treated with Herbicidal Glyphosate Formulations | MONSANTO TECHNOLOGY LLC (US) | 2017-11-30 | — | — | US | disclosed |
| CN-104585228-B | Mitigating necrosis in transgenic glyphosate-tolerant cotton plants treated with herbicidal glyphosate formulations | 孟山都技术公司 | 2017-05-24 | — | — | CN | disclosed |
| US-9642359-B2 | Mitigating necrosis in transgenic glyphosate-tolerant cotton plants treated with herbicidal glyphosate formulations | MONSANTO TECHNOLOGY LLC (US) | 2017-05-09 | — | — | US | disclosed |
| US-20160330956-A1 | Mitigating Necrosis in Transgenic Glyphosate-Tolerant Cotton Plants Treated with Herbicidal Glyphosate Formulations | MONSANTO TECHNOLOGY LLC (US) | 2016-11-17 | — | — | US | disclosed |
| US-9364003-B2 | Mitigating necrosis in transgenic glyphosate-tolerant cotton plants treated with herbicidal glyphosate formulations | MONSANTO TECHNOLOGY LLC (US) | 2016-06-14 | — | — | US | disclosed |
| EP-0554007-B1 | Catalytic synthesis of alkyl morpholinones | HUNTSMAN CORP (US) | 1998-05-27 | — | — | EP | disclosed |
| EP-0425929-B1 | Process for the preparation of N-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxy-piperidine and of intermediates | BAYER AG (DE) | 1995-12-06 | — | — | EP | disclosed |
| EP-0554007-A1 | Catalytic synthesis of alkyl morpholinones | Huntsman Corporation (US) | 1993-08-04 | — | — | EP | disclosed |
| US-5136035-A | Catalytic synthesis of alkyl morpholinones | TEXACO CHEMICAL COMPANY (US) | 1992-08-04 | — | — | US | disclosed |
| EP-0217250-B1 | FOAMING SURFACTANT PREPARATIONS WITH CLEAR, SOLUBILIZED WATER INSOLUBLE OIL COMPONENTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1992-04-08 | — | — | EP | disclosed |
| EP-0288919-B1 | GELLED FOAM BATH CONCENTRATE | Henkel Kommanditgesellschaft auf Aktien (DE) | 1992-03-04 | — | — | EP | disclosed |
| US-5071990-A | PREPARATION OF INTERMEDIATES AND THE SYNTHESIS OF N-(2-HYDROXYETHYL)-2-HYDROXYMETHYL-3,4,5-TRIHYDROXYPIPERIDINES | BAYER AKTIENGESELLSCHAFT (DE) | 1991-12-10 | — | — | US | disclosed |
| US-5066804-A | Preparation of alkyl morpholinones | TEXACO CHEMICAL COMPANY (US) | 1991-11-19 | — | — | US | disclosed |
| EP-0217250-A2 | Foaming surfactant preparations with clear, solubilized water insoluble oil components | Henkel Kommanditgesellschaft auf Aktien (DE) | 1987-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200236930-A1 | Mitigating Necrosis in Transgenic Glyphosate-Tolerant Cotton Plants Treated with Herbicidal Glyphosate Formulations | GLO1, AGXT, GRHPR | TDP1 681/4885EYA2 2368/4885APP 2809/4885 |
| US-20170339950-A1 | Mitigating Necrosis in Transgenic Glyphosate-Tolerant Cotton Plants Treated with Herbicidal Glyphosate Formulations | GLO1, AGXT, GRHPR | TDP1 681/4885EYA2 2368/4885APP 2809/4885 |
| US-20230102424-A1 | Mitigating Necrosis in Transgenic Glyphosate-Tolerant Cotton Plants Treated with Herbicidal Glyphosate Formulations | GLO1, AGXT, GRHPR | TDP1 681/4885EYA2 2368/4885APP 2809/4885 |
| US-20160330956-A1 | Mitigating Necrosis in Transgenic Glyphosate-Tolerant Cotton Plants Treated with Herbicidal Glyphosate Formulations | GLO1, AGXT, GRHPR | TDP1 681/4885EYA2 2368/4885APP 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.